Target intelligence / Profile preview

Dendritic cell–T cell interaction (DC-T cell interaction)

Target
DC-T cell interaction
Molecular classification
Biological process, Cellular interaction
01

Overview

Dendritic cell–T cell interaction is a fundamental biological process where dendritic cells (DCs), acting as professional antigen-presenting cells, communicate with T cells to initiate or regulate immune responses (Mellman & Steinman, 2001, Nature). This interaction occurs at the immunological synapse and involves the presentation of antigenic peptides via Major Histocompatibility Complex (MHC) molecules to the T-cell receptor (TCR), alongside various costimulatory and coinhibitory signals (Dustin, 2014, Nature Reviews Immunology). While critical for defending against pathogens and tumors, dysregulation of this interaction can lead to autoimmune diseases or immune evasion by cancers (Banchereau & Steinman, 1998, Nature). Therapeutic strategies often target specific molecules within this interface, such as CTLA-4 or PD-1/PD-L1, to either enhance or suppress the resulting T-cell activity (Sharma & Allison, 2015, Science). Because it encompasses a complex network of multiple receptors and ligands rather than a single protein, it is classified as a cellular process rather than a discrete molecular target.

Other names
DC-T cell synapseImmunological synapseAntigen presentationDC-T cell crosstalkT cell priming
02

Mechanism of action

Modulation of costimulatory and coinhibitory signaling pathways within the immunological synapse to regulate T-cell activation and effector function.

03

Biological functions

Antigen presentationT cell activationImmune responseImmune toleranceSignal transductionCytokine production
04

Disease associations

CancerAutoimmune diseaseInfectionInflammationGraft-versus-host disease
05

Safety considerations

Immune-related adverse events (irAEs)Cytokine release syndromeAutoimmunitySystemic immunosuppressionInfusion reactions
06

Interacting drugs

Abatacept

6 more in the full profile.

07

Biomarkers

CD80CD86MHC class IIPD-L1 expressionInterferon-gammaCD40

Beyond the preview

Go deeper on Dendritic cell–T cell interaction (DC-T cell interaction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell–T cell interaction (DC-T cell interaction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call